IA
ACER

IFP Advisors’s Acer Therapeutics Inc ACER Stock Holding History

IFP Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed – – 4252
2017
Q2 		$0 Hold
1
– – ﹤0.01% 4251
2017
Q1 		$0 Hold
1
– – ﹤0.01% 4168
2016
Q4 		$0 Hold
1
– – ﹤0.01% 4174
2016
Q3 		$0 Hold
1
– – ﹤0.01% 4087
2016
Q2 		$0 Buy
+1
New +$30 ﹤0.01% 4124
2016
Q1 		– Sell
-1
Closed – – 3588
2015
Q4 		$0 Buy
+1
New +$33 ﹤0.01% 3816

Other funds holding ACER

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IFP Advisors's ACER Position: Q3 2017 in Review

IFP Advisors sold out of Acer Therapeutics Inc (ACER) in Q3 2017, closing a stake of 1 share.

IFP Advisors first reported a position in ACER in Q4 2015 and held it in 6 quarters. The position peaked at $0 in Q2 2017. 4 funds tracked by Wall St. Rank hold ACER as of Q3 2017.

  • IFP Advisors reported no remaining Acer Therapeutics Inc position as of Q3 2017 after selling out during the quarter.
  • IFP Advisors sold 1 Acer Therapeutics Inc share in Q3 2017.
  • IFP Advisors first reported a position in Acer Therapeutics Inc in Q4 2015 and held it in 6 quarters.
  • IFP Advisors's Acer Therapeutics Inc position peaked at $0 in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2017.

Based on IFP Advisors's 13F filing for Q3 2017, filed 30 Oct 2017.